我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
17
2 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1949
已完成
8
47.1%
尚未招募
2
11.8%
招募中
6
35.3%
Unknown
1
5.9%
暂无批准数据
- Toro Neurovascular received FDA 510(k) clearance for its Toro 88 Superbore Catheter, marking the company's first proprietary neurovascular access catheter platform designed for modern stroke interventions. - Radical Catheter Technologies obtained FDA clearance for its 6F neurovascular catheter, expanding therapeutic options particularly for middle-meningeal artery embolization and radial access procedures. - Both catheters feature innovative engineering solutions to address physician-identified performance gaps in complex neurovascular procedures requiring enhanced support, trackability, and stability. - The clearances represent significant milestones for advancing stroke care and complex cerebrovascular interventions through next-generation catheter technology.
